Abstract:A Disintegrin And Metalloproteinase 12 (ADAM12) is highly expressed in multiple cancers such as breast and cervical cancers and its high expression reduces the overall patient survival rate. ADAM12 has two major splicing variants, the long membrane-anchored form ADAM12L and the short secreted form ADAM12S. However, how they are regulated and whether they are modulated similarly or differently in cells are not clear. Here, we use affinity purification and mass spectrometry to identify the ADAM12S-interacting proteins. Spectral counting and MaxQuant label-free quantification reveal that ADAM12S but not ADAM12L specifically interacts with a subset of endoplasmic reticulum proteins, such as endoplasmin (GRP94), 78 kDa glucose-regulated protein (GRP78), and UDP-glucose:glycoprotein glucosyltransferase I (UGGT1), that regulate the folding and processing of secreted proteins. Further biochemical experiments validate the interaction between ADAM12S and several of its interacting proteins. Computational docking analysis demonstrates that GRP94 preferentially interacts with ADAM12S over ADAM12L. The data also suggest that both the protein expression level and the secretion of ADAM12S are regulated by GRP94 expression and knockdown. Our results reveal a link between these two proteins that are highly expressed in cancer cells. Furthermore, our studies define a new ADAM12S-specific regulator that may contribute to the cancer development. Significance: A Disintegrin And Metalloproteinase 12 (ADAM12) is highly expressed in many cancers such as lung, breast, and cervical cancers. ADAM12 has two major splicing variants, the long membrane-anchored form ADAM12L and the short secreted form ADAM12S. However, how they are regulated and whether they are modulated similarly or differently are not completely understood. We use affinity purification and label-free quantitative proteomics to identify the ADAM12S-interacting proteins. Our results reveal that ADAM12S specifically interacts with a subset of endoplasmic reticulum proteins, including endoplasmin (GRP94), UDP-glucose:glycoprotein glucosyltransferase I (UGGT1), and neutral α-glucosidase AB (GANAB). Computer modeling reveals that ADAM12S interacts with the surface amino acids of GRP94 more strongly than ADAM12L. Biochemical experiments further reveal that GRP94 regulates both the protein level and the secretion of ADAM12S. Database mining finds that both GRP94 and ADAM12 are highly expressed in multiple cancers and their high expression is correlated with poor patient survival rate. Taken together, our work discovers a new upstream regulator for ADAM12S, which may contribute to its distinct functions in the regulation of the migration and invasion of cancer cells.

The Expression of ADAM12 (meltrin Alpha) in Human Giant Cell Tumours of Bone.

[Expression of ADAM12 (Meltrin-Alpha) Gene in Giant Cell Tumor of Bone].

Expression of ADAMTS12 in Colorectal Cancer-Associated Stroma Prevents Cancer Development and is a Good Prognostic Indicator of Colorectal Cancer

[Expression of a Disintegrin-Like and Metalloproteinase Protein 8 and 12 in the Giant Cell Lesions of Jaw].

[Expression of Macrophage Inflammatory Protein-1Alpha, a Disintegrin-Like and Metalloproteinase 8 and 12, and CD68 Protein in Giant Cell Lesions of Jaw and Giant Cell Tumors of Long Bone].

Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype

Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma

Expression And Localization Of Extracellular Matrix Metalloproteinase Inducer In Giant Cell Tumor Of Bone

The Expression And Regulation Of Adamts13 In Hematopoietic System.

Methylation Status of ADAM12 Promoter Are Associated with Its Expression Levels in Colorectal Cancer.

Quantitative Proteomics Identifies Myoferlin As a Novel Regulator of A Disintegrin and Metalloproteinase 12 in HeLa Cells.

ADAMTS12 Promotes Migration and Epithelial-Mesenchymal Transition and Predicts Poor Prognosis for Pancreatic Cancer.

ADAMTS12, a Novel Prognostic Predictor, Promotes Cell Proliferation, Migration and Invasion in Head and Neck Squamous Cell Carcinoma.

Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12.

The Role of SnoN in Transforming Growth Factor β1-induced Expression of Metalloprotease-Disintegrin ADAM12

Expression and Clinical Significance of a Disintegrin and Metalloproteinase-12 and Proliferating Cell Nuclear Antigen in Bladder Carcinoma

An Essential Role of Metalloprotease-Disintegrin ADAM12 in Triple-Negative Breast Cancer

ADAMTS12 Mediates Vascular Abnormality to Enhance Chemoresistance Via the MAPK/VEGF Signaling Pathway in Gastric Cancer

Metalloprotease-Disintegrin Adam12 Expression Is Regulated By Notch Signaling Via Microrna-29b

Prognostic Values for the Mrna Expression of the ADAMTS Family of Genes in Gastric Cancer